NEWS RELEASE

Teijin to Exhibit Biomass Bisphenol A PC Resin at Chinaplas 2023

Tokyo, Japan, March 30, 2023 ---Teijin Limited will attendChinaplas 2023 (booth No. 17K91) to exhibit its new biomass-derived bisphenol A (BPA) polycarbonate (PC) resin products, which was certified as a ISCC PLUS sustainable-product by the International Sustainability and Carbon Certification (ISCC) system in January. Teijin will be the first Japanese firm to showcase an ISCC PLUS-certified PC resin products.

Teijin facilities in Japan are now producing biomass PC resin products that contain BPA made from biomass naphtha tracked with the mass-balance approach. Under this approach, materials are verifiably tracked through complex value chains, as in the case of biomass-derived raw materials that are mixed with petroleum-derived raw materials in final products.

Biomass PC resin, which offers the same physical properties as resins made of petroleum-derived BPA, is suitable for many commercial applications including the automotive, telecommunication and healthcare fields.

Going forward, Teijin expects to continue enhancing its lineup of eco-friendly Circular Materials (CM) made with biomass-derived PC resin Panlite® CM.

Chinaplas 2023, Asia's largest exhibition for the plastics and rubber industries, will be held at the Shenzhen World Exhibition & Convention Center in China from April 17 to 20.

About the Teijin Group

Teijin (TSE: 3401) is a technology-driven global group offering advanced solutions in the fields of environmental value; safety, security and disaster mitigation; and demographic change and increased health consciousness. Originally established as Japan's first rayon manufacturer in 1918, Teijin has evolved into a unique enterprise encompassing three core business domains: high-performance materials including aramid, carbon fibers and composites, and also resin and plastic processing, films, polyester fibers andproducts converting; healthcare including pharmaceuticals and home healthcare equipment for bone/joint, respiratory and cardiovascular/metabolic diseases, nursing care and pre-symptomatic healthcare; and IT including B2B solutions for medical, corporate and public systems as well as packaged software and B2C online services for digital entertainment. Deeply committed to its stakeholders, as expressed in the brand statement "Human Chemistry, Human Solutions", Teijin aims to be a company that supports the society of the future. The group comprises some 170 companies and employs some 20,000 people across 20 countries worldwide. Teijin posted consolidated sales of JPY 926.1 billion (USD 7.2 billion) and total assets of JPY 1,207.6 billion (USD 9.4 billion) in the fiscal year that ended on March 31, 2022.

Press Contact

Investor and Public Relations Department Teijin Limitedpr@teijin.co.jp

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

Teijin Limited published this content on 30 March 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 30 March 2023 02:10:04 UTC.